Comments
Loading...
Biogen Earnings Estimates, EPS & Revenue | NASDAQ:BIIB | Benzinga
Biogen reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Apr 23
EPS Estimate
$3.960
Quarterly Revenue Estimate
$2.32B
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$9.68B
Analyze the earnings history of Biogen using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BIIB | Biogen | $3.67 | $3.96 | — | — | $2.29B | $2.32B | — | — | 04/23/2025 | Get Alert |
| BIIB | Biogen | $2.95 | $3.35 | $3.44 | 2.69% | $2.39B | $2.40B | $2.46B | 2.29% | 02/12/2025 | Get Alert |
| BIIB | Biogen | $4.36 | $3.79 | $4.08 | 7.65% | $2.53B | $2.43B | $2.47B | 1.48% | 10/30/2024 | Get Alert |
| BIIB | Biogen | $4.02 | $4.02 | $5.28 | 31.34% | $2.46B | $2.38B | $2.46B | 3.57% | 08/01/2024 | Get Alert |
| BIIB | Biogen | $3.40 | $3.44 | $3.67 | 6.69% | $2.46B | $2.31B | $2.29B | -0.82% | 04/24/2024 | Get Alert |
| BIIB | Biogen | $4.05 | $3.18 | $2.95 | -7.23% | $2.54B | $2.46B | $2.39B | -3.20% | 02/13/2024 | Get Alert |
| BIIB | Biogen | $4.77 | $3.99 | $4.36 | 9.27% | $2.51B | $2.39B | $2.53B | 5.86% | 11/08/2023 | Get Alert |
| BIIB | Biogen | $5.25 | $3.77 | $4.02 | 6.63% | $2.59B | $2.37B | $2.46B | 3.63% | 07/25/2023 | Get Alert |
| BIIB | Biogen | $3.62 | $3.28 | $3.40 | 3.66% | $2.53B | $2.34B | $2.46B | 5.26% | 04/25/2023 | Get Alert |
| BIIB | Biogen | $3.39 | $3.48 | $4.05 | 16.38% | $2.73B | $2.44B | $2.54B | 4.26% | 02/15/2023 | Get Alert |
| BIIB | Biogen | $4.77 | $4.16 | $4.77 | 14.66% | $2.78B | $2.47B | $2.51B | 1.56% | 10/25/2022 | Get Alert |
| BIIB | Biogen | $5.68 | $4.10 | $5.25 | 28.05% | $2.77B | $2.48B | $2.59B | 4.40% | 07/20/2022 | Get Alert |
| BIIB | Biogen | $5.34 | $4.38 | $3.62 | -17.35% | $2.69B | $2.49B | $2.53B | 1.69% | 05/03/2022 | Get Alert |
| BIIB | Biogen | $4.58 | $3.40 | $3.39 | -0.29% | $2.85B | $2.62B | $2.73B | 4.35% | 02/03/2022 | Get Alert |
| BIIB | Biogen | $8.84 | $4.11 | $4.77 | 16.06% | $3.38B | $2.67B | $2.78B | 4.08% | 10/20/2021 | Get Alert |
| BIIB | Biogen | $10.26 | $4.55 | $5.68 | 24.84% | $3.68B | $2.61B | $2.77B | 6.32% | 07/22/2021 | Get Alert |
| BIIB | Biogen | $9.14 | $5.04 | $5.34 | 5.95% | $3.53B | $2.65B | $2.69B | 1.66% | 04/22/2021 | Get Alert |
| BIIB | Biogen | $8.34 | $4.87 | $4.58 | -5.95% | $3.67B | $2.80B | $2.85B | 1.88% | 02/03/2021 | Get Alert |
| BIIB | Biogen | $9.17 | $8.13 | $8.84 | 8.73% | $3.60B | $3.35B | $3.38B | 0.78% | 10/21/2020 | Get Alert |
| BIIB | Biogen | $9.15 | $8.04 | $10.26 | 27.61% | $3.62B | $3.44B | $3.68B | 7.03% | 07/22/2020 | Get Alert |
| BIIB | Biogen | $6.98 | $7.74 | $9.14 | 18.09% | $3.49B | $3.41B | $3.53B | 3.64% | 04/22/2020 | Get Alert |
Biogen (BIIB) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-12 | $3.44 | $3.35 | 2.69 % |
| Q3 | 2024-10-30 | $4.08 | $3.79 | 7.65 % |
| Q2 | 2024-08-01 | $5.28 | $4.02 | 31.3 % |
| Q1 | 2024-04-24 | $3.67 | $3.44 | 6.69 % |
Biogen (BIIB) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-12 | $2.46B | $2.40B | 2.29 % |
| Q3 | 2024-10-30 | $2.47B | $2.43B | 1.48 % |
| Q2 | 2024-08-01 | $2.47B | $2.38B | 3.57 % |
| Q1 | 2024-04-24 | $2.29B | $2.31B | -0.82 % |
FAQ
When is Biogen (NASDAQ:BIIB) reporting earnings?
Biogen (BIIB) is scheduled to report earnings on April 23, 2025. The last reported earnings were for reported on February 12, 2025 for Q4.
What were the latest earnings per share (EPS) for Biogen (NASDAQ:BIIB)?
The Actual EPS was $3.44, which beat the estimate of $3.35.
What were Biogen’s (NASDAQ:BIIB) revenues?
The Actual Revenue was $2.5B, which beat the estimate of $2.4B.
Browse earnings estimates, EPS, and revenue on all stocks.